Biologics
Total Trials
5
As Lead Sponsor
As Collaborator
0
Total Enrollment
539
NCT03667716
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
Phase: Phase 1
Role: Lead Sponsor
Start: Sep 6, 2018
Completion: Jan 30, 2024
NCT04354246
COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies
Start: Mar 31, 2020
Completion: Dec 30, 2025
NCT04570839
COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors.
Phase: Phase 1/2
Start: Aug 31, 2020
Completion: May 15, 2024
NCT06759649
A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
Start: Jan 7, 2025
Completion: Nov 22, 2027
NCT06888921
A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian Cancer
Start: Jul 21, 2025
Completion: Mar 31, 2027
Loading map...